Compare CLDX & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | WLDN |
|---|---|---|
| Founded | N/A | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2008 | 2006 |
| Metric | CLDX | WLDN |
|---|---|---|
| Price | $25.87 | $126.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $44.10 | ★ $117.00 |
| AVG Volume (30 Days) | ★ 738.8K | 273.8K |
| Earning Date | 02-26-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 71.17 |
| EPS | N/A | ★ 2.79 |
| Revenue | $2,599,000.00 | ★ $651,926,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.23 | $9.01 |
| P/E Ratio | ★ N/A | $45.54 |
| Revenue Growth | N/A | ★ 12.90 |
| 52 Week Low | $14.40 | $30.43 |
| 52 Week High | $30.50 | $127.82 |
| Indicator | CLDX | WLDN |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 71.43 |
| Support Level | $25.15 | $108.00 |
| Resistance Level | $28.00 | $127.82 |
| Average True Range (ATR) | 1.16 | 5.11 |
| MACD | -0.09 | 1.50 |
| Stochastic Oscillator | 28.96 | 95.36 |
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.